nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Tamoxifen—pancreatic cancer	0.0529	0.116	CbGbCtD
Boceprevir—CYP3A5—Erlotinib—pancreatic cancer	0.045	0.0985	CbGbCtD
Boceprevir—CYP3A5—Irinotecan—pancreatic cancer	0.0406	0.089	CbGbCtD
Boceprevir—ABCB1—Tamoxifen—pancreatic cancer	0.0344	0.0754	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—pancreatic cancer	0.0298	0.0652	CbGbCtD
Boceprevir—ABCB1—Gemcitabine—pancreatic cancer	0.0296	0.065	CbGbCtD
Boceprevir—CYP3A5—Sunitinib—pancreatic cancer	0.0296	0.0649	CbGbCtD
Boceprevir—ABCB1—Erlotinib—pancreatic cancer	0.0293	0.0641	CbGbCtD
Boceprevir—ABCB1—Irinotecan—pancreatic cancer	0.0264	0.0579	CbGbCtD
Boceprevir—CYP3A4—Tamoxifen—pancreatic cancer	0.0206	0.0452	CbGbCtD
Boceprevir—ABCB1—Docetaxel—pancreatic cancer	0.0194	0.0424	CbGbCtD
Boceprevir—ABCB1—Sunitinib—pancreatic cancer	0.0193	0.0422	CbGbCtD
Boceprevir—CYP3A4—Erlotinib—pancreatic cancer	0.0175	0.0384	CbGbCtD
Boceprevir—CYP3A4—Irinotecan—pancreatic cancer	0.0158	0.0347	CbGbCtD
Boceprevir—Telaprevir—CELA1—pancreatic cancer	0.0148	1	CrCbGaD
Boceprevir—ABCB1—Doxorubicin—pancreatic cancer	0.0144	0.0316	CbGbCtD
Boceprevir—CYP3A4—Docetaxel—pancreatic cancer	0.0116	0.0254	CbGbCtD
Boceprevir—CYP3A4—Sunitinib—pancreatic cancer	0.0115	0.0253	CbGbCtD
Boceprevir—CYP3A4—Doxorubicin—pancreatic cancer	0.00865	0.019	CbGbCtD
Boceprevir—CTSV—islet of Langerhans—pancreatic cancer	0.00813	0.115	CbGeAlD
Boceprevir—CTSK—gall bladder—pancreatic cancer	0.00764	0.108	CbGeAlD
Boceprevir—CTSS—gall bladder—pancreatic cancer	0.00669	0.0948	CbGeAlD
Boceprevir—CTSL—islet of Langerhans—pancreatic cancer	0.00664	0.0942	CbGeAlD
Boceprevir—CTSV—pancreas—pancreatic cancer	0.00572	0.081	CbGeAlD
Boceprevir—CTSL—pancreas—pancreatic cancer	0.00467	0.0662	CbGeAlD
Boceprevir—CMA1—digestive system—pancreatic cancer	0.00466	0.0661	CbGeAlD
Boceprevir—CTSS—islet of Langerhans—pancreatic cancer	0.00439	0.0622	CbGeAlD
Boceprevir—CTSL—digestive system—pancreatic cancer	0.00399	0.0565	CbGeAlD
Boceprevir—CTSK—pancreas—pancreatic cancer	0.00352	0.0499	CbGeAlD
Boceprevir—CTSS—pancreas—pancreatic cancer	0.00308	0.0437	CbGeAlD
Boceprevir—CTSK—digestive system—pancreatic cancer	0.00301	0.0426	CbGeAlD
Boceprevir—CTSS—digestive system—pancreatic cancer	0.00263	0.0373	CbGeAlD
Boceprevir—CYP3A5—islet of Langerhans—pancreatic cancer	0.00146	0.0206	CbGeAlD
Boceprevir—CYP3A5—pancreas—pancreatic cancer	0.00102	0.0145	CbGeAlD
Boceprevir—CYP3A5—digestive system—pancreatic cancer	0.000875	0.0124	CbGeAlD
Boceprevir—ABCB1—islet of Langerhans—pancreatic cancer	0.000774	0.011	CbGeAlD
Boceprevir—CYP3A4—digestive system—pancreatic cancer	0.000656	0.0093	CbGeAlD
Boceprevir—ABCB1—pancreas—pancreatic cancer	0.000544	0.00771	CbGeAlD
Boceprevir—ABCB1—digestive system—pancreatic cancer	0.000465	0.00658	CbGeAlD
Boceprevir—Bronchitis—Doxorubicin—pancreatic cancer	0.000131	0.000439	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00013	0.000436	CcSEcCtD
Boceprevir—Arthralgia—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Boceprevir—Chest pain—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Boceprevir—Myalgia—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Boceprevir—Nausea—Sunitinib—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Boceprevir—Asthenia—Irinotecan—pancreatic cancer	0.000129	0.000432	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000129	0.000431	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000128	0.000431	CcSEcCtD
Boceprevir—Stomatitis—Epirubicin—pancreatic cancer	0.000128	0.000429	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—pancreatic cancer	0.000127	0.000428	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—pancreatic cancer	0.000127	0.000428	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—pancreatic cancer	0.000127	0.000427	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—pancreatic cancer	0.000127	0.000427	CcSEcCtD
Boceprevir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000127	0.000425	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—pancreatic cancer	0.000127	0.000425	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—pancreatic cancer	0.000126	0.000422	CcSEcCtD
Boceprevir—Asthenia—Gemcitabine—pancreatic cancer	0.000125	0.000421	CcSEcCtD
Boceprevir—Confusional state—Docetaxel—pancreatic cancer	0.000125	0.00042	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000124	0.000417	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000124	0.000416	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—pancreatic cancer	0.000124	0.000415	CcSEcCtD
Boceprevir—Pruritus—Gemcitabine—pancreatic cancer	0.000124	0.000415	CcSEcCtD
Boceprevir—Infection—Docetaxel—pancreatic cancer	0.000123	0.000413	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—pancreatic cancer	0.000123	0.000413	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—pancreatic cancer	0.000123	0.000413	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000123	0.000412	CcSEcCtD
Boceprevir—Diarrhoea—Irinotecan—pancreatic cancer	0.000123	0.000412	CcSEcCtD
Boceprevir—Agranulocytosis—Epirubicin—pancreatic cancer	0.000122	0.000411	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—pancreatic cancer	0.000122	0.00041	CcSEcCtD
Boceprevir—Shock—Docetaxel—pancreatic cancer	0.000122	0.000409	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000122	0.000408	CcSEcCtD
Boceprevir—Pruritus—Fluorouracil—pancreatic cancer	0.000122	0.000408	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000121	0.000407	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000121	0.000407	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—pancreatic cancer	0.000121	0.000407	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—pancreatic cancer	0.000121	0.000406	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—pancreatic cancer	0.00012	0.000404	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00012	0.000404	CcSEcCtD
Boceprevir—Diarrhoea—Gemcitabine—pancreatic cancer	0.00012	0.000401	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000119	0.000399	CcSEcCtD
Boceprevir—Dizziness—Irinotecan—pancreatic cancer	0.000119	0.000398	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—pancreatic cancer	0.000118	0.000397	CcSEcCtD
Boceprevir—Rhinitis—Epirubicin—pancreatic cancer	0.000118	0.000396	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000118	0.000396	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000118	0.000396	CcSEcCtD
Boceprevir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000118	0.000394	CcSEcCtD
Boceprevir—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000117	0.000393	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—pancreatic cancer	0.000117	0.000392	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000116	0.00039	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—pancreatic cancer	0.000116	0.000389	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—pancreatic cancer	0.000116	0.000389	CcSEcCtD
Boceprevir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000116	0.000388	CcSEcCtD
Boceprevir—Urethral disorder—Epirubicin—pancreatic cancer	0.000115	0.000387	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000115	0.000385	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—pancreatic cancer	0.000114	0.000384	CcSEcCtD
Boceprevir—Vomiting—Irinotecan—pancreatic cancer	0.000114	0.000383	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—pancreatic cancer	0.000114	0.000382	CcSEcCtD
Boceprevir—Dizziness—Fluorouracil—pancreatic cancer	0.000114	0.000381	CcSEcCtD
Boceprevir—Visual impairment—Epirubicin—pancreatic cancer	0.000113	0.000381	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000113	0.00038	CcSEcCtD
Boceprevir—Rash—Irinotecan—pancreatic cancer	0.000113	0.00038	CcSEcCtD
Boceprevir—Dermatitis—Irinotecan—pancreatic cancer	0.000113	0.000379	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000113	0.000379	CcSEcCtD
Boceprevir—Headache—Irinotecan—pancreatic cancer	0.000112	0.000377	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—pancreatic cancer	0.000112	0.000376	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—pancreatic cancer	0.000111	0.000374	CcSEcCtD
Boceprevir—Erythema multiforme—Epirubicin—pancreatic cancer	0.000111	0.000374	CcSEcCtD
Boceprevir—Vomiting—Gemcitabine—pancreatic cancer	0.000111	0.000373	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—pancreatic cancer	0.000111	0.000371	CcSEcCtD
Boceprevir—Rash—Gemcitabine—pancreatic cancer	0.00011	0.00037	CcSEcCtD
Boceprevir—Dermatitis—Gemcitabine—pancreatic cancer	0.00011	0.000369	CcSEcCtD
Boceprevir—Eye disorder—Epirubicin—pancreatic cancer	0.00011	0.000369	CcSEcCtD
Boceprevir—Tinnitus—Epirubicin—pancreatic cancer	0.00011	0.000368	CcSEcCtD
Boceprevir—Headache—Gemcitabine—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Boceprevir—Flushing—Epirubicin—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Boceprevir—Vomiting—Fluorouracil—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—pancreatic cancer	0.000109	0.000366	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—pancreatic cancer	0.000109	0.000366	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000108	0.000364	CcSEcCtD
Boceprevir—Rash—Fluorouracil—pancreatic cancer	0.000108	0.000364	CcSEcCtD
Boceprevir—Dermatitis—Fluorouracil—pancreatic cancer	0.000108	0.000363	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—pancreatic cancer	0.000108	0.000363	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—pancreatic cancer	0.000108	0.000362	CcSEcCtD
Boceprevir—Headache—Fluorouracil—pancreatic cancer	0.000108	0.000361	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000108	0.000361	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000107	0.00036	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000107	0.000359	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000107	0.000359	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—pancreatic cancer	0.000107	0.000359	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—pancreatic cancer	0.000107	0.000358	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—pancreatic cancer	0.000107	0.000358	CcSEcCtD
Boceprevir—Nausea—Irinotecan—pancreatic cancer	0.000107	0.000358	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—pancreatic cancer	0.000106	0.000357	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000106	0.000356	CcSEcCtD
Boceprevir—Pain—Docetaxel—pancreatic cancer	0.000106	0.000356	CcSEcCtD
Boceprevir—Constipation—Docetaxel—pancreatic cancer	0.000106	0.000356	CcSEcCtD
Boceprevir—Chills—Epirubicin—pancreatic cancer	0.000106	0.000354	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—pancreatic cancer	0.000105	0.000353	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—pancreatic cancer	0.000105	0.000352	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—pancreatic cancer	0.000104	0.000349	CcSEcCtD
Boceprevir—Nausea—Gemcitabine—pancreatic cancer	0.000104	0.000348	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—pancreatic cancer	0.000103	0.000346	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000103	0.000346	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Boceprevir—Erythema—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—pancreatic cancer	0.000102	0.000343	CcSEcCtD
Boceprevir—Nausea—Fluorouracil—pancreatic cancer	0.000102	0.000342	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—pancreatic cancer	0.000102	0.000342	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—pancreatic cancer	0.000102	0.000341	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000101	0.00034	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—pancreatic cancer	0.000101	0.000339	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000101	0.000339	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—pancreatic cancer	0.000101	0.000339	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—pancreatic cancer	0.0001	0.000337	CcSEcCtD
Boceprevir—Back pain—Epirubicin—pancreatic cancer	9.91e-05	0.000333	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—pancreatic cancer	9.88e-05	0.000332	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—pancreatic cancer	9.85e-05	0.000331	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—pancreatic cancer	9.84e-05	0.00033	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.82e-05	0.000329	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—pancreatic cancer	9.8e-05	0.000329	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—pancreatic cancer	9.8e-05	0.000329	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NRAS—pancreatic cancer	9.8e-05	0.000611	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—pancreatic cancer	9.8e-05	0.000611	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GCG—pancreatic cancer	9.78e-05	0.00061	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—SRC—pancreatic cancer	9.78e-05	0.00061	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SRC—pancreatic cancer	9.78e-05	0.00061	CbGpPWpGaD
Boceprevir—Chills—Doxorubicin—pancreatic cancer	9.77e-05	0.000328	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—pancreatic cancer	9.73e-05	0.000327	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	9.73e-05	0.000607	CbGpPWpGaD
Boceprevir—Vision blurred—Epirubicin—pancreatic cancer	9.66e-05	0.000324	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—pancreatic cancer	9.63e-05	0.000323	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PIK3CD—pancreatic cancer	9.55e-05	0.000596	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGF—pancreatic cancer	9.55e-05	0.000596	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGF—pancreatic cancer	9.55e-05	0.000596	CbGpPWpGaD
Boceprevir—Mental disorder—Doxorubicin—pancreatic cancer	9.54e-05	0.00032	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—pancreatic cancer	9.51e-05	0.000319	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—pancreatic cancer	9.48e-05	0.000318	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—pancreatic cancer	9.48e-05	0.000318	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—pancreatic cancer	9.47e-05	0.000318	CcSEcCtD
Boceprevir—Agitation—Epirubicin—pancreatic cancer	9.42e-05	0.000316	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—NRAS—pancreatic cancer	9.41e-05	0.000587	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—pancreatic cancer	9.41e-05	0.000587	CbGpPWpGaD
Boceprevir—Flatulence—Doxorubicin—pancreatic cancer	9.34e-05	0.000314	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CTNNB1—pancreatic cancer	9.34e-05	0.000583	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR1—pancreatic cancer	9.33e-05	0.000582	CbGpPWpGaD
Boceprevir—Dysgeusia—Doxorubicin—pancreatic cancer	9.29e-05	0.000312	CcSEcCtD
Boceprevir—Malaise—Epirubicin—pancreatic cancer	9.24e-05	0.00031	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—pancreatic cancer	9.21e-05	0.000309	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—STK11—pancreatic cancer	9.2e-05	0.000574	CbGpPWpGaD
Boceprevir—Syncope—Epirubicin—pancreatic cancer	9.19e-05	0.000308	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—pancreatic cancer	9.17e-05	0.000308	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—pancreatic cancer	9.17e-05	0.000308	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CTNNB1—pancreatic cancer	9.15e-05	0.000571	CbGpPWpGaD
Boceprevir—Hypersensitivity—Docetaxel—pancreatic cancer	9.14e-05	0.000307	CcSEcCtD
Boceprevir—CTSK—Immune System—BCL2L1—pancreatic cancer	9.12e-05	0.000569	CbGpPWpGaD
Boceprevir—Muscle spasms—Doxorubicin—pancreatic cancer	9.12e-05	0.000306	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—PTEN—pancreatic cancer	9.1e-05	0.000568	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TSC2—pancreatic cancer	9.06e-05	0.000566	CbGpPWpGaD
Boceprevir—Palpitations—Epirubicin—pancreatic cancer	9.06e-05	0.000304	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—pancreatic cancer	9.01e-05	0.000302	CcSEcCtD
Boceprevir—Cough—Epirubicin—pancreatic cancer	8.94e-05	0.0003	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—pancreatic cancer	8.94e-05	0.0003	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—EGFR—pancreatic cancer	8.93e-05	0.000557	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—pancreatic cancer	8.93e-05	0.000557	CbGpPWpGaD
Boceprevir—Asthenia—Docetaxel—pancreatic cancer	8.9e-05	0.000299	CcSEcCtD
Boceprevir—CTSL—Immune System—CDH1—pancreatic cancer	8.89e-05	0.000555	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—pancreatic cancer	8.89e-05	0.000555	CbGpPWpGaD
Boceprevir—Hypertension—Epirubicin—pancreatic cancer	8.85e-05	0.000297	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.8e-05	0.000295	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—pancreatic cancer	8.77e-05	0.000294	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—pancreatic cancer	8.76e-05	0.000294	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PTEN—pancreatic cancer	8.74e-05	0.000545	CbGpPWpGaD
Boceprevir—Chest pain—Epirubicin—pancreatic cancer	8.73e-05	0.000293	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—pancreatic cancer	8.73e-05	0.000293	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—pancreatic cancer	8.73e-05	0.000293	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—pancreatic cancer	8.71e-05	0.000292	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—pancreatic cancer	8.69e-05	0.000292	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PIK3CB—pancreatic cancer	8.67e-05	0.000541	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.66e-05	0.000291	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—pancreatic cancer	8.62e-05	0.000289	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—EGFR—pancreatic cancer	8.57e-05	0.000535	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—pancreatic cancer	8.57e-05	0.000535	CbGpPWpGaD
Boceprevir—Malaise—Doxorubicin—pancreatic cancer	8.55e-05	0.000287	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—pancreatic cancer	8.53e-05	0.000286	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—pancreatic cancer	8.52e-05	0.000286	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—pancreatic cancer	8.5e-05	0.000285	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	8.5e-05	0.000531	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CD—pancreatic cancer	8.49e-05	0.00053	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CD—pancreatic cancer	8.49e-05	0.00053	CbGpPWpGaD
Boceprevir—Leukopenia—Doxorubicin—pancreatic cancer	8.49e-05	0.000285	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—pancreatic cancer	8.48e-05	0.000285	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—SRC—pancreatic cancer	8.44e-05	0.000527	CbGpPWpGaD
Boceprevir—Confusional state—Epirubicin—pancreatic cancer	8.43e-05	0.000283	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—KRAS—pancreatic cancer	8.43e-05	0.000526	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—pancreatic cancer	8.43e-05	0.000526	CbGpPWpGaD
Boceprevir—Palpitations—Doxorubicin—pancreatic cancer	8.38e-05	0.000281	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	8.36e-05	0.000521	CbGpPWpGaD
Boceprevir—Loss of consciousness—Doxorubicin—pancreatic cancer	8.33e-05	0.00028	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PIK3CB—pancreatic cancer	8.33e-05	0.00052	CbGpPWpGaD
Boceprevir—Infection—Epirubicin—pancreatic cancer	8.31e-05	0.000279	CcSEcCtD
Boceprevir—Cough—Doxorubicin—pancreatic cancer	8.27e-05	0.000278	CcSEcCtD
Boceprevir—CTSK—Immune System—NFKBIA—pancreatic cancer	8.27e-05	0.000516	CbGpPWpGaD
Boceprevir—Shock—Epirubicin—pancreatic cancer	8.23e-05	0.000276	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—pancreatic cancer	8.2e-05	0.000275	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—pancreatic cancer	8.2e-05	0.000275	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—pancreatic cancer	8.19e-05	0.000275	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—pancreatic cancer	8.19e-05	0.000275	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—pancreatic cancer	8.16e-05	0.000274	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—pancreatic cancer	8.12e-05	0.000273	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—pancreatic cancer	8.12e-05	0.000507	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SRC—pancreatic cancer	8.1e-05	0.000506	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—pancreatic cancer	8.1e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—pancreatic cancer	8.1e-05	0.000505	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Epirubicin—pancreatic cancer	8.09e-05	0.000271	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—pancreatic cancer	8.07e-05	0.000271	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—pancreatic cancer	8.07e-05	0.000271	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—pancreatic cancer	8.07e-05	0.000271	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SMAD4—pancreatic cancer	8.06e-05	0.000503	CbGpPWpGaD
Boceprevir—Anxiety—Doxorubicin—pancreatic cancer	8.05e-05	0.00027	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.02e-05	0.000269	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—pancreatic cancer	7.98e-05	0.000268	CcSEcCtD
Boceprevir—CTSK—Immune System—EGF—pancreatic cancer	7.91e-05	0.000494	CbGpPWpGaD
Boceprevir—Dry mouth—Doxorubicin—pancreatic cancer	7.9e-05	0.000265	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—pancreatic cancer	7.88e-05	0.000265	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HES1—pancreatic cancer	7.87e-05	0.000491	CbGpPWpGaD
Boceprevir—Rash—Docetaxel—pancreatic cancer	7.82e-05	0.000262	CcSEcCtD
Boceprevir—Hypotension—Epirubicin—pancreatic cancer	7.82e-05	0.000262	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—pancreatic cancer	7.81e-05	0.000262	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—pancreatic cancer	7.8e-05	0.000262	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—pancreatic cancer	7.8e-05	0.000487	CbGpPWpGaD
Boceprevir—Headache—Docetaxel—pancreatic cancer	7.77e-05	0.000261	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—PIK3CA—pancreatic cancer	7.75e-05	0.000484	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—pancreatic cancer	7.75e-05	0.000484	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTNNB1—pancreatic cancer	7.69e-05	0.00048	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—pancreatic cancer	7.69e-05	0.000258	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.62e-05	0.000256	CcSEcCtD
Boceprevir—Shock—Doxorubicin—pancreatic cancer	7.61e-05	0.000255	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—pancreatic cancer	7.59e-05	0.000255	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.58e-05	0.000254	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—pancreatic cancer	7.56e-05	0.000254	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—pancreatic cancer	7.55e-05	0.000253	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—pancreatic cancer	7.52e-05	0.000252	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—pancreatic cancer	7.51e-05	0.000252	CcSEcCtD
Boceprevir—CTSS—Immune System—BCL2L1—pancreatic cancer	7.51e-05	0.000469	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—pancreatic cancer	7.49e-05	0.000468	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.48e-05	0.000251	CcSEcCtD
Boceprevir—CTSS—Immune System—TSC2—pancreatic cancer	7.46e-05	0.000466	CbGpPWpGaD
Boceprevir—Dyspnoea—Epirubicin—pancreatic cancer	7.46e-05	0.00025	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—pancreatic cancer	7.44e-05	0.000464	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—pancreatic cancer	7.44e-05	0.000464	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CB—pancreatic cancer	7.4e-05	0.000462	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CB—pancreatic cancer	7.4e-05	0.000462	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—pancreatic cancer	7.4e-05	0.000462	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	7.38e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—pancreatic cancer	7.37e-05	0.00046	CbGpPWpGaD
Boceprevir—Nausea—Docetaxel—pancreatic cancer	7.37e-05	0.000247	CcSEcCtD
Boceprevir—Dyspepsia—Epirubicin—pancreatic cancer	7.36e-05	0.000247	CcSEcCtD
Boceprevir—Decreased appetite—Epirubicin—pancreatic cancer	7.27e-05	0.000244	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—pancreatic cancer	7.23e-05	0.000243	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.22e-05	0.000242	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—pancreatic cancer	7.21e-05	0.000242	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTEN—pancreatic cancer	7.2e-05	0.000449	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—pancreatic cancer	7.17e-05	0.000447	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—pancreatic cancer	7.17e-05	0.000447	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	7.16e-05	0.000447	CbGpPWpGaD
Boceprevir—Constipation—Epirubicin—pancreatic cancer	7.15e-05	0.00024	CcSEcCtD
Boceprevir—Pain—Epirubicin—pancreatic cancer	7.15e-05	0.00024	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—EGFR—pancreatic cancer	7.1e-05	0.000443	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.05e-05	0.000237	CcSEcCtD
Boceprevir—CTSK—Immune System—PIK3CD—pancreatic cancer	7.04e-05	0.000439	CbGpPWpGaD
Boceprevir—Insomnia—Doxorubicin—pancreatic cancer	7e-05	0.000235	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—pancreatic cancer	6.99e-05	0.000436	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—SRC—pancreatic cancer	6.95e-05	0.000434	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—pancreatic cancer	6.95e-05	0.000233	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—pancreatic cancer	6.9e-05	0.000232	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—pancreatic cancer	6.89e-05	0.000231	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—TERT—pancreatic cancer	6.89e-05	0.00043	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—pancreatic cancer	6.88e-05	0.00043	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—pancreatic cancer	6.88e-05	0.00043	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.84e-05	0.00023	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—pancreatic cancer	6.81e-05	0.000229	CcSEcCtD
Boceprevir—CTSS—Immune System—NFKBIA—pancreatic cancer	6.81e-05	0.000425	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	6.74e-05	0.000421	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—pancreatic cancer	6.73e-05	0.000226	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KRAS—pancreatic cancer	6.71e-05	0.000419	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—pancreatic cancer	6.69e-05	0.000417	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.68e-05	0.000224	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—SRC—pancreatic cancer	6.67e-05	0.000416	CbGpPWpGaD
Boceprevir—Fatigue—Doxorubicin—pancreatic cancer	6.67e-05	0.000224	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—pancreatic cancer	6.64e-05	0.000223	CcSEcCtD
Boceprevir—Pain—Doxorubicin—pancreatic cancer	6.62e-05	0.000222	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—pancreatic cancer	6.62e-05	0.000222	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—pancreatic cancer	6.61e-05	0.000222	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—pancreatic cancer	6.61e-05	0.000222	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HIF1A—pancreatic cancer	6.59e-05	0.000411	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TSC2—pancreatic cancer	6.57e-05	0.00041	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTNNB1—pancreatic cancer	6.56e-05	0.00041	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—pancreatic cancer	6.56e-05	0.00041	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGF—pancreatic cancer	6.52e-05	0.000407	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	6.47e-05	0.000404	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	6.45e-05	0.000403	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—pancreatic cancer	6.43e-05	0.000402	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—pancreatic cancer	6.42e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—pancreatic cancer	6.42e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—pancreatic cancer	6.4e-05	0.000399	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—pancreatic cancer	6.4e-05	0.000399	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—pancreatic cancer	6.38e-05	0.000214	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—AKT1—pancreatic cancer	6.33e-05	0.000395	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—pancreatic cancer	6.33e-05	0.000395	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.33e-05	0.000212	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	6.32e-05	0.000395	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—pancreatic cancer	6.3e-05	0.000393	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.27e-05	0.000391	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—pancreatic cancer	6.16e-05	0.000385	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—pancreatic cancer	6.16e-05	0.000207	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.15e-05	0.000384	CbGpPWpGaD
Boceprevir—Urticaria—Doxorubicin—pancreatic cancer	6.15e-05	0.000206	CcSEcCtD
Boceprevir—CTSK—Immune System—PIK3CB—pancreatic cancer	6.13e-05	0.000383	CbGpPWpGaD
Boceprevir—Abdominal pain—Doxorubicin—pancreatic cancer	6.12e-05	0.000205	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—pancreatic cancer	6.12e-05	0.000205	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—EGFR—pancreatic cancer	6.09e-05	0.00038	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—pancreatic cancer	6.08e-05	0.000379	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—pancreatic cancer	6.08e-05	0.000379	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—pancreatic cancer	6.07e-05	0.000379	CbGpPWpGaD
Boceprevir—Asthenia—Epirubicin—pancreatic cancer	6e-05	0.000201	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NFKBIA—pancreatic cancer	6e-05	0.000374	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—pancreatic cancer	5.94e-05	0.000371	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH1—pancreatic cancer	5.94e-05	0.000371	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SRC—pancreatic cancer	5.93e-05	0.00037	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SRC—pancreatic cancer	5.93e-05	0.00037	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—pancreatic cancer	5.92e-05	0.000199	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—EGFR—pancreatic cancer	5.85e-05	0.000365	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CG—pancreatic cancer	5.81e-05	0.000362	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CD—pancreatic cancer	5.79e-05	0.000362	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—pancreatic cancer	5.75e-05	0.000359	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGF—pancreatic cancer	5.74e-05	0.000358	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—pancreatic cancer	5.72e-05	0.000192	CcSEcCtD
Boceprevir—CTSV—Immune System—STAT3—pancreatic cancer	5.72e-05	0.000357	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—pancreatic cancer	5.72e-05	0.000357	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—pancreatic cancer	5.71e-05	0.000356	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—pancreatic cancer	5.71e-05	0.000356	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—pancreatic cancer	5.7e-05	0.000356	CbGpPWpGaD
Boceprevir—Hypersensitivity—Doxorubicin—pancreatic cancer	5.7e-05	0.000191	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—pancreatic cancer	5.55e-05	0.000186	CcSEcCtD
Boceprevir—Dizziness—Epirubicin—pancreatic cancer	5.53e-05	0.000186	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—KRAS—pancreatic cancer	5.53e-05	0.000345	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—pancreatic cancer	5.48e-05	0.000184	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	5.47e-05	0.000342	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—pancreatic cancer	5.44e-05	0.000339	CbGpPWpGaD
Boceprevir—Vomiting—Epirubicin—pancreatic cancer	5.32e-05	0.000178	CcSEcCtD
Boceprevir—CTSK—Immune System—PTEN—pancreatic cancer	5.3e-05	0.000331	CbGpPWpGaD
Boceprevir—Diarrhoea—Doxorubicin—pancreatic cancer	5.3e-05	0.000178	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PIK3CA—pancreatic cancer	5.29e-05	0.00033	CbGpPWpGaD
Boceprevir—Rash—Epirubicin—pancreatic cancer	5.27e-05	0.000177	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—pancreatic cancer	5.27e-05	0.000177	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—AKT1—pancreatic cancer	5.24e-05	0.000327	CbGpPWpGaD
Boceprevir—Headache—Epirubicin—pancreatic cancer	5.24e-05	0.000176	CcSEcCtD
Boceprevir—CTSL—Immune System—EGFR—pancreatic cancer	5.2e-05	0.000324	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—pancreatic cancer	5.2e-05	0.000324	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—pancreatic cancer	5.12e-05	0.000172	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PIK3CD—pancreatic cancer	5.1e-05	0.000319	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—pancreatic cancer	5.08e-05	0.000317	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CB—pancreatic cancer	5.05e-05	0.000315	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—pancreatic cancer	5.04e-05	0.000314	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	5.02e-05	0.000314	CbGpPWpGaD
Boceprevir—Nausea—Epirubicin—pancreatic cancer	4.97e-05	0.000167	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—pancreatic cancer	4.92e-05	0.000165	CcSEcCtD
Boceprevir—CTSK—Immune System—SRC—pancreatic cancer	4.92e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—pancreatic cancer	4.91e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—pancreatic cancer	4.91e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—pancreatic cancer	4.89e-05	0.000305	CbGpPWpGaD
Boceprevir—Rash—Doxorubicin—pancreatic cancer	4.88e-05	0.000164	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—pancreatic cancer	4.88e-05	0.000164	CcSEcCtD
Boceprevir—Headache—Doxorubicin—pancreatic cancer	4.85e-05	0.000163	CcSEcCtD
Boceprevir—CTSK—Immune System—STAT3—pancreatic cancer	4.74e-05	0.000296	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—pancreatic cancer	4.73e-05	0.000295	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—pancreatic cancer	4.7e-05	0.000293	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—pancreatic cancer	4.69e-05	0.000293	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.66e-05	0.000291	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—pancreatic cancer	4.6e-05	0.000154	CcSEcCtD
Boceprevir—CTSL—Immune System—PIK3CA—pancreatic cancer	4.51e-05	0.000282	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—pancreatic cancer	4.51e-05	0.000282	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—pancreatic cancer	4.48e-05	0.000279	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.47e-05	0.000279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CB—pancreatic cancer	4.45e-05	0.000278	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PRSS1—pancreatic cancer	4.43e-05	0.000276	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—pancreatic cancer	4.36e-05	0.000272	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—pancreatic cancer	4.32e-05	0.00027	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—pancreatic cancer	4.31e-05	0.000269	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—pancreatic cancer	4.28e-05	0.000267	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—pancreatic cancer	4.17e-05	0.000261	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—pancreatic cancer	4.17e-05	0.000261	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—pancreatic cancer	4.15e-05	0.000259	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—pancreatic cancer	4.09e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—pancreatic cancer	4.07e-05	0.000254	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.07e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SRC—pancreatic cancer	4.05e-05	0.000253	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.03e-05	0.000252	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—pancreatic cancer	3.98e-05	0.000249	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—pancreatic cancer	3.94e-05	0.000246	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—pancreatic cancer	3.9e-05	0.000244	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—pancreatic cancer	3.89e-05	0.000243	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—pancreatic cancer	3.87e-05	0.000241	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—pancreatic cancer	3.84e-05	0.00024	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ARG2—pancreatic cancer	3.84e-05	0.00024	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—pancreatic cancer	3.74e-05	0.000233	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—pancreatic cancer	3.69e-05	0.00023	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—pancreatic cancer	3.69e-05	0.00023	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—pancreatic cancer	3.57e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—pancreatic cancer	3.55e-05	0.000221	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—pancreatic cancer	3.47e-05	0.000217	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—pancreatic cancer	3.46e-05	0.000216	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—pancreatic cancer	3.44e-05	0.000215	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—pancreatic cancer	3.43e-05	0.000214	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.43e-05	0.000214	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMP—pancreatic cancer	3.36e-05	0.000209	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—pancreatic cancer	3.35e-05	0.000209	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.34e-05	0.000209	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—pancreatic cancer	3.2e-05	0.000199	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—pancreatic cancer	3.19e-05	0.000199	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.18e-05	0.000199	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—pancreatic cancer	3.13e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.1e-05	0.000193	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—pancreatic cancer	3.08e-05	0.000192	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.07e-05	0.000192	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—pancreatic cancer	3.05e-05	0.000191	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.99e-05	0.000187	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—pancreatic cancer	2.95e-05	0.000184	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ARG2—pancreatic cancer	2.9e-05	0.000181	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—pancreatic cancer	2.85e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.77e-05	0.000173	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—pancreatic cancer	2.71e-05	0.000169	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GLP1R—pancreatic cancer	2.71e-05	0.000169	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.7e-05	0.000169	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DPYD—pancreatic cancer	2.66e-05	0.000166	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—pancreatic cancer	2.62e-05	0.000164	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMP—pancreatic cancer	2.53e-05	0.000158	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	2.53e-05	0.000158	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—pancreatic cancer	2.52e-05	0.000157	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—pancreatic cancer	2.51e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.49e-05	0.000155	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.48e-05	0.000155	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.43e-05	0.000152	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.32e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.3e-05	0.000143	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—pancreatic cancer	2.22e-05	0.000138	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.11e-05	0.000132	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.06e-05	0.000129	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.04e-05	0.000127	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.04e-05	0.000127	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DPYD—pancreatic cancer	2.01e-05	0.000125	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD44—pancreatic cancer	1.96e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.91e-05	0.000119	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCG—pancreatic cancer	1.88e-05	0.000117	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.79e-05	0.000111	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STK11—pancreatic cancer	1.76e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.72e-05	0.000108	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.56e-05	9.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.52e-05	9.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD44—pancreatic cancer	1.48e-05	9.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCG—pancreatic cancer	1.42e-05	8.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STK11—pancreatic cancer	1.33e-05	8.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.26e-05	7.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.24e-05	7.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—pancreatic cancer	1.23e-05	7.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.17e-05	7.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—pancreatic cancer	1.14e-05	7.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.11e-05	6.95e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.07e-05	6.71e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	9.79e-06	6.11e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—pancreatic cancer	9.31e-06	5.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD44—pancreatic cancer	9.09e-06	5.68e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCG—pancreatic cancer	8.72e-06	5.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	8.53e-06	5.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—pancreatic cancer	8.45e-06	5.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—pancreatic cancer	8.4e-06	5.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STK11—pancreatic cancer	8.2e-06	5.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—pancreatic cancer	8.11e-06	5.06e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.39e-06	4.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—pancreatic cancer	7.37e-06	4.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.05e-06	4.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.44e-06	4.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.38e-06	3.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—pancreatic cancer	5.74e-06	3.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—pancreatic cancer	5.56e-06	3.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	5.2e-06	3.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.18e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—pancreatic cancer	5e-06	3.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.55e-06	2.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—pancreatic cancer	4.25e-06	2.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.97e-06	2.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.93e-06	2.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.92e-06	2.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.43e-06	2.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—pancreatic cancer	3.21e-06	2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.42e-06	1.51e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.98e-06	1.23e-05	CbGpPWpGaD
